Treatment

Updates on German clinical trials in multiple myeloma

Prevention and management of adverse events in relapsed myeloma

Bringing Dara into the first-line for multiple myeloma

Myeloma XI study update: KCRD for NDMM

Clinical management of plasma cell leukemia: an update

Diagnosing and treating solitary plasmacytoma

Relapsed myeloma treatment: what’s ahead?

Delaying transplant in the young and fit MM patient

Anti-CD38 CAR NK-cells: an off-the shelf therapy for multiple myeloma

Managing CRS after anti-BCMA CAR-T for myeloma

CAR-T in myeloma: what is the potential?

Preventing progression to multiple myeloma

Genomic advances in MM disease biology

CyborD-DARA combination in first-line treatment for multiple myeloma

Progression of multiple myeloma novel therapies with Prof. Nagler

Rationale for NK-cell therapy in myeloma